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OBJECTIVE — We hypothesized that labile A1C (LA1C) is directly correlated with stable
A1C (SA1C) and between-patient differences in SA1C, which are independent of mean blood
glucose (MBG).
RESEARCH DESIGN AND METHODS — We measured SA1C, LA1C, MBG, and a
single clinic capillary glucose (CCG) from 152 pediatric patients with type 1 diabetes. Patients
were grouped as high, moderate, or low glycators by hemoglobin glycation index (HGI).
RESULTS — LA1C and SA1C were correlated with CCG and MBG. LA1C was not correlated
with SA1C (r  0.06, P  0.453). LA1C level was signiﬁcantly associated with glycator group
status (P  0.0019) and CCG (P  0.0001). Adjusted LA1C levels were highest in the low-HGI
patients and lowest in the high-HGI group.
CONCLUSIONS — A conventional model of SA1C being directly correlated with LA1C
concentrationwasnotconﬁrmed.Between-patientdifferencesinSA1CatthesameMBGmaybe
due to complex intracellular factors inﬂuencing formation of SA1C from LA1C.
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O
ur team and others have described
groups of diabetic patients who
consistently demonstrate markedly
higher (high glycators) or lower (low gly-
cators) A1C despite both groups having
similar preceding mean blood glucose
(MBG) (1,2). As A1C is formed by the
stable Amadori rearrangement of a pre-
cursor known as labile A1C (LA1C) (3),
we hypothesized that high glycators
would also have higher levels of LA1C,
compared with low glycators. We tested
this hypothesis in a well-characterized
group of children with type 1 diabetes.
RESEARCH DESIGN AND
METHODS— Participants were pa-
tients with type 1 diabetes followed in the
pediatric diabetes clinics at Children’s
HospitalofNewOrleans.Participantshad
MBG calculated from data uploaded from
the patient’s home glucose meter and
a sample drawn for A1C at each clinic
visit. Visits were approximately every 3
months. A clinic capillary glucose (CCG)
measurement was obtained at each visit
using an Accu-Chek Inform.
A1C was assayed by a capillary isoelec-
tric focusing method (4). LA1C was re-
moved by incubation of 100 l isolated
erythrocytes for6ha t37°C in 1 ml PBS.
Stable A1C (SA1C) was the level after incu-
bation. LA1C was the difference in A1C be-
fore and after incubation. LA1C and SA1C
are expressed as a percent of total HbA0,
based on peak area of absorbance at 415
nm. SA1C levels for this method were not
standardized to the Diabetes Control and
ComplicationsTrial(DCCT)assaymethod.
Glycatorstatusofpatientswasassigned
bycalculationofahemoglobinglycationin-
dex (HGI) from each patient’s SA1C and
MBG, as previously described (1) (2).
Brieﬂy, HGI is the difference between the
patient’s observed and predicted SA1C.
Predicted SA1C was calculated by inserting
the patient’s MBG into the regression equa-
tion describing the relationship between
SA1C and MBG for our patient population
(SA1C  [0.031  MBG]  5.4). All pa-
tients were then ranked by HGI tertile and
grouped as high-, moderate-, or low-HGI
glycators (1).
Statistical methods
Assessment of the inﬂuence of HGI group
on LA1C was performed with adjustment
for covariates (sex, BMI, duration of dia-
betes, and CCG). The difference between
adjusted least-square means of LA1C for
the HGI group in the model was evalu-
ated. A model was also ﬁtted with LA1C
(expressed as a percent of total A1C) as
the dependent variable and HGI group,
sex, BMI, duration of diabetes, and CCG
as covariates.
RESULTS— Demographic and glyce-
miccharacteristicsfortheglycatorgroups
are presented in Table 1. There were sta-
tistically signiﬁcant differences between
groups for CCG, HGI, and SA1C. MBG
for the HGI groups were similar. A multi-
ple linear regression model with LA1C as
the dependent variable and HGI group,
CCG, sex, BMI, and duration of diabetes
as the independent variables was per-
formed (overall r
2  0.295, P  0.0001).
Only HGI group (P  0.0019) and CCG
(P  0.0001) were statistically associated
with LA1C in this model.
LA1C was not correlated with SA1C
(r  0.06, P  0.45). LA1C was correlated
withbothMBG(r0.30,P0.0002)and
CCG (r  0.47, P  0.0001). SA1C was
correlated with both MBG (r  0.62, P 
0.0001) and CCG (r  0.38, P  0.0001).
CONCLUSIONS — In the conven-
tionally understood model of SA1C for-
mation, glucose enters the red blood cell
(RBC) and nonenzymatically binds rap-
idly and reversibly to hemoglobin form-
ing a Schiff base referred to as LA1C (3).
Over longer periods of time, LA1C can
undergo irreversible Amadori rearrange-
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SA1Caccumulatesintracellularlyoverthe
lifespan of the RBC. The model suggests
that formation of SA1C is proportional to
theconcentrationofprecursormoieties,a
conceptsupportedinpartbytheobserva-
tion that LA1C is correlated with concur-
rent clinic glucose level (CCG) and SA1C
is correlated with MBG. Based on this ba-
sic model, we hypothesized that LA1C
would be correlated with SA1C and that
high glycators would have correspond-
ingly high levels of LA1C compared with
low glycators. Contrary to our expecta-
tions,wefoundthat1)theconcentrations
of LA1C and SA1C within RBCs were not
correlated and 2) low glycators had the
highest levels of LA1C adjusted for the
concurrent glucose level.
DifferencesinSA1Cbetweenindivid-
uals and species despite similar MBG
might be due to differences in intracellu-
lar glucose levels (5–8). However, if
higher CCG and MBG lead to higher in-
tracellular glucose concentrations, this
does not appear to translate into higher
LA1C levels for high glycators in vivo.
Thus, factors in addition to intracellular
glucose concentration may inﬂuence
LA1CandsubsequentformationofSA1C,
contributing to observed differences be-
tweenhighandlowglycatorsdespitesim-
ilar MBG. LA1C is 60 times more likely to
revert back to free glucose and hemoglo-
bin than form SA1C (9). Thus, relatively
minor changes in conditions may alter
subsequent formation of SA1C from
LA1C. Potential altering factors may be
intracellular pH, competitive binding of
glucose and other metabolites, other iso-
forms of LA1C, and deglycating enzymes
(10). Thus, intra-RBC factors may favor
accumulation of LA1C over formation of
SA1C in low glycators.
Although deﬁnitive evidence is not yet
available, there are several potential expla-
nations for lack of correlation between
LA1C and SA1C, although both are corre-
lated to a lesser or greater degree to CCG
and MBG. Different isoforms of LA1C with
different association/dissociation kinetics
(11), the short time frame (minutes to
hours) of LA1C formation/dissociation
compared with longer formation (days to
weeks) of SA1C (9), RBC longevity, oxida-
tivestatus,anddeglycatingenzymesmayall
differentially inﬂuence levels of LA1C com-
pared with SA1C. These factors potentially
lead to the observed differences in propor-
tion of LA1C to SA1C and HGI between
individuals.
Low glycators are at less risk for mi-
crovascular complications than high
glycators(2,12,13).Itistemptingtospec-
ulate that higher LA1C could serve as a
temporary intracellular storage compart-
ment for glucose and/or some of its
intracellular metabolites. Temporary se-
questering of glucose or glucose metabo-
lites as LA1C would prevent these
substances from entering pathways that
produce toxic metabolites when blood
glucose levels are elevated.
The process by which hemoglobin
and other proteins become glycated is
likely more complex than conventionally
described. Our ﬁndings suggest that fac-
tors in addition to simple concentration
dependent kinetics play a role in the for-
mation of SA1C and observed biological
variationbetweenhighandlowglycators.
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Table 1—Demographic characteristics and glycemic measurements by HGI group status
HGI
group n Age (years)
Duration
of diabetes
(years)
Sex
(n male/
female) HGI*
MBG
(mg/dl)
CCG
(mg/dl) SA1C* (%)
Adjusted
LA1C (%)
LA1C
(% total A1C)
High 54 13.1  3.6 5.6  3.6
b 27/27 1.85  1.20
a 195  48 276  106
a 13.4  1.8
a 1.88
b 13.6  6.0
c
Moderate 52 12.6  4.1 4.7  3.5
b 25/27 0.07  0.44
b 181  31 225  86
b 11.0  1.1
b 2.33
ab 16.5  6.3
b
Low 46 12.1  3.7 3.9  3.0
a 27/19 1.79  0.74
c 187  45 221  104
b 9.5  1.5
c 2.60
a 20.0  6.6
a
Data are means  SD. *HGI and SA1C are different between groups due to group selection.
abcGroup values within a column having different superscripts are
signiﬁcantly different (P  0.05) from each other.
Labile A1C and HGI
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